Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms TREAT
- Sponsors Centocor; Janssen Biotech
- 19 Jul 2018 Results published in the American Journal of Gastroenterology
- 13 Aug 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.